BR112013016905A2 - métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano - Google Patents
métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humanoInfo
- Publication number
- BR112013016905A2 BR112013016905A2 BR112013016905A BR112013016905A BR112013016905A2 BR 112013016905 A2 BR112013016905 A2 BR 112013016905A2 BR 112013016905 A BR112013016905 A BR 112013016905A BR 112013016905 A BR112013016905 A BR 112013016905A BR 112013016905 A2 BR112013016905 A2 BR 112013016905A2
- Authority
- BR
- Brazil
- Prior art keywords
- children
- human milk
- infants
- milk oligosaccharides
- methods
- Prior art date
Links
- 210000004251 human milk Anatomy 0.000 title abstract 4
- 235000020256 human milk Nutrition 0.000 title abstract 4
- 229920001542 oligosaccharide Polymers 0.000 title abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 4
- 206010051606 Necrotising colitis Diseases 0.000 title abstract 3
- 208000004995 necrotizing enterocolitis Diseases 0.000 title abstract 3
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Pediatric Medicine (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
Abstract
métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano são revelados métodos para redução da incidência de enterocolite necrosante em bebês, crianças pequenas ou crianças usando composições nutricionais incluindo oligossacarídeos do leite humano. as composições nutricionais incluindo os oligossacarídeos do leite humano são eficazes na redução inflamatória e na incidência de doenças inflamatórias.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061428868P | 2010-12-31 | 2010-12-31 | |
US201061428863P | 2010-12-31 | 2010-12-31 | |
PCT/US2011/067018 WO2012092156A1 (en) | 2010-12-31 | 2011-12-22 | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013016905A2 true BR112013016905A2 (pt) | 2019-09-24 |
Family
ID=45509697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013016905A BR112013016905A2 (pt) | 2010-12-31 | 2011-12-22 | métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano |
Country Status (10)
Country | Link |
---|---|
US (5) | US9539269B2 (pt) |
EP (1) | EP2658547A1 (pt) |
CN (1) | CN107019701B (pt) |
BR (1) | BR112013016905A2 (pt) |
CA (1) | CA2822219C (pt) |
MX (3) | MX2013007692A (pt) |
MY (2) | MY197622A (pt) |
NZ (1) | NZ611807A (pt) |
SG (3) | SG191392A1 (pt) |
WO (1) | WO2012092156A1 (pt) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ612214A (en) | 2010-12-29 | 2015-02-27 | Abbott Lab | Nutritional products including monoglycerides and fatty acids |
NZ611807A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
DK2658549T3 (da) | 2010-12-31 | 2020-06-29 | Abbott Lab | Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler |
WO2013016111A1 (en) | 2011-07-22 | 2013-01-31 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
EP2836218A4 (en) * | 2012-04-13 | 2015-10-21 | Trustees Boston College | PROBIOTIC COMPOSITIONS AND METHODS OF USE |
DK2708147T3 (da) * | 2012-09-14 | 2020-05-18 | Abbott Lab | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose |
DK2708145T3 (en) * | 2012-09-14 | 2016-07-18 | Abbott Lab | Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals |
FR2997819B1 (fr) | 2012-11-14 | 2015-06-26 | Roquette Freres | Utilisation de polysaccharides dans le bien etre intestinal du nourisson et/ou du jeune enfant |
WO2014100022A1 (en) * | 2012-12-18 | 2014-06-26 | Abbott Laboratories | Dietary oligosaccharides to enhance learning and memory |
CA2893217C (en) * | 2012-12-18 | 2017-11-28 | Abbott Laboratories | Human milk oligosaccharides to ameliorate symptoms of stress |
US10624916B2 (en) * | 2012-12-20 | 2020-04-21 | Abbott Laboratories | Nutritional formulations using human milk oligosaccharides for modulating inflammation |
CA2901469A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc. | Rice protein supplements |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
US9352020B2 (en) * | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
MX2013003636A (es) * | 2013-03-27 | 2014-09-29 | Palsgaard Ind De Mexico S De R L De C V | Complemento alimenticio para personas con trisomia 21, transtorno del espectro autista y/o transtorno por deficit de atencion con o sin hiperactividad. |
WO2015071402A1 (en) * | 2013-11-15 | 2015-05-21 | Nestec S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children |
WO2015071401A1 (en) * | 2013-11-15 | 2015-05-21 | Nestec S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section |
RU2016123515A (ru) | 2013-11-15 | 2017-12-20 | Нестек С.А. | Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного и младшего возраста |
US10568896B2 (en) | 2013-11-19 | 2020-02-25 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
EP2888950A1 (en) * | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
SG11201608248YA (en) | 2014-04-08 | 2016-10-28 | Abbott Lab | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides |
US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
BR112017003920A2 (pt) | 2014-09-25 | 2017-12-12 | Nestec Sa | sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos) |
JP7182872B2 (ja) * | 2014-10-29 | 2022-12-05 | グリコム・アクティーゼルスカブ | 過敏性腸症候群の治療のための合成組成物および方法 |
US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
EP3212198B1 (en) * | 2014-10-29 | 2020-12-23 | Glycom A/S | Synthetic composition and method for promoting mucosal healing |
BR112017007375A2 (pt) | 2014-10-31 | 2017-12-19 | Nestec Sa | composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral |
CN106998775A (zh) * | 2014-11-26 | 2017-08-01 | 雅培制药有限公司 | 具有RRR‑α‑生育酚、2’‑岩藻糖基乳糖和益生菌的婴儿配方 |
PT3264923T (pt) * | 2015-03-05 | 2023-04-11 | Nestle Sa | Composições para utilização na prevenção ou tratamento de infeções gastrointestinais em lactentes ou crianças pequenas |
CN107405354A (zh) * | 2015-03-05 | 2017-11-28 | 格礼卡姆股份公司 | 治疗急性呼吸道感染的组合物和方法 |
RU2020107846A (ru) | 2015-03-05 | 2020-03-16 | Сосьете Де Продюи Нестле С.А. | Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста |
EP3264921A1 (en) | 2015-03-05 | 2018-01-10 | Nestec S.A. | Compositions for use in improving stool consistency or frequency in infants or young children |
WO2017021476A1 (en) | 2015-08-04 | 2017-02-09 | Nestec S.A. | Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants |
WO2017198276A1 (en) * | 2016-05-19 | 2017-11-23 | Glycom A/S | Synthetic composition |
EP3478093A4 (en) | 2016-07-01 | 2020-03-04 | Evolve Biosystems, Inc. | METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM |
US20190160082A1 (en) * | 2016-08-04 | 2019-05-30 | Nestec S.A. | Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis |
US20180064739A1 (en) * | 2016-09-06 | 2018-03-08 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
WO2018067923A1 (en) * | 2016-10-06 | 2018-04-12 | Tallgrass Therapeutics, Llc | Compositions and methods for the prevention and treatment of colitis in infants |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
US11541068B2 (en) * | 2017-05-24 | 2023-01-03 | Glycom A/S | HMO compositions and methods for reducing autism spectrum disorder symptoms |
US11541067B2 (en) * | 2017-05-24 | 2023-01-03 | Glycom A/S | HMO compositions and methods for reducing detrimental proteolytic metabolites |
IL271112B2 (en) | 2017-06-21 | 2023-11-01 | Abbott Lab | Methods to increase the growth of beneficial bacteria in the digestive system |
WO2019008105A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
AU2018295414A1 (en) * | 2017-07-07 | 2020-01-16 | Societe Des Produits Nestle S.A. | Human milk fortifier |
CN107467677A (zh) * | 2017-08-22 | 2017-12-15 | 北京特食生物科技研究中心(有限合伙) | 一种润肠通便、维持肠道健康的复合营养品及其制备方法与应用 |
CN111698994A (zh) * | 2017-11-30 | 2020-09-22 | 格礼卡姆股份公司 | 治疗小麦敏感性的hmo混合物 |
EP3727399A1 (en) * | 2017-12-21 | 2020-10-28 | Société des Produits Nestlé S.A. | Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility |
GB2573539A (en) * | 2018-05-09 | 2019-11-13 | Mjn Us Holdings Llc | Wellbeing supplement for postpartum maternal nutrition |
CN111248289B (zh) * | 2018-11-30 | 2023-04-07 | 内蒙古伊利实业集团股份有限公司 | 一种组合物、其制备方法及用途 |
WO2020159357A1 (en) | 2019-02-01 | 2020-08-06 | N.V. Nutricia | Native whey protein for treating and/or preventing intestinal infection |
US11849747B1 (en) | 2019-06-24 | 2023-12-26 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
JP7474596B2 (ja) | 2020-01-20 | 2024-04-25 | 森永乳業株式会社 | 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物 |
CN112870234B (zh) * | 2021-01-27 | 2023-06-02 | 四川九章生物科技有限公司 | 包含绿原酸的药物组合物在制备治疗病理性黄疸的药物中的用途 |
CN113273695B (zh) * | 2021-06-03 | 2022-05-17 | 海普诺凯营养品有限公司 | 一种改善新生儿溶血性高胆红素血症的组合物 |
Family Cites Families (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4762822A (en) | 1985-08-08 | 1988-08-09 | Ettinger Anna C | Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides |
US5260280A (en) | 1989-02-07 | 1993-11-09 | Snow Brand Milk Products Co., Ltd. | Bacterial toxin neutralizer |
JPH03266255A (ja) | 1990-03-15 | 1991-11-27 | Canon Inc | オートチェンジャ |
US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
SE468536B (sv) | 1991-07-03 | 1993-02-01 | Bolin Mauritz Ingf Ab | Stickkontakt |
EP0727216B1 (en) | 1994-07-15 | 2003-05-28 | TAIYO KAGAKU Co., LTD. | Medicinal composition containing sialic acid derivative |
JPH08266255A (ja) | 1995-03-30 | 1996-10-15 | Taiyo Kagaku Co Ltd | 学習能力向上組成物 |
WO1997048388A1 (en) | 1996-06-17 | 1997-12-24 | The Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
JP3552856B2 (ja) | 1996-09-27 | 2004-08-11 | 雪印乳業株式会社 | 栄養強化組成物 |
DE19701382A1 (de) | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
DK1039892T3 (da) | 1997-02-21 | 2004-08-30 | Univ Tennessee Res Foundation | Anvendelse af polyumættede fedtsyrer til reducering af forekomsten af nekrotiserende enterocolitis |
US6080787A (en) | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
SA98190002B1 (ar) | 1997-03-28 | 2006-06-20 | ذي يونيفيرسيتي اوف تننيسي ريسيرش كوربوريشن | استخدام أحماض دهنية تحتوي على عدة روابط غير مشبعة polyunsaturated fatty acids لتقليل حدوث الالتهاب المعوي القولوني الناخر incidence of necrotizing enterocolitis |
US6045854A (en) | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
US5906982A (en) | 1997-03-31 | 1999-05-25 | Abbott Laboratories | Nutritional formulations containing Lacto-N-neoTetraose |
JPH10327804A (ja) | 1997-06-04 | 1998-12-15 | Meiji Milk Prod Co Ltd | 核酸関連物質、dha、アラキドン酸及び コレステロール含有栄養組成物 |
US20020019991A1 (en) | 1998-04-30 | 2002-02-14 | Abbott Laboratories | Compositions containing an alpha 1,2-fucose linkage and uses thereof |
US6294206B1 (en) | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
US6497908B1 (en) | 1999-07-19 | 2002-12-24 | Seiri Oshiro | Turmeric-containing cooking oils and fats |
DE19958985A1 (de) | 1999-12-07 | 2001-06-13 | Nutricia Nv | Oligosaccharidmischung |
US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US6630452B2 (en) | 2000-02-17 | 2003-10-07 | Wyeth | Nutritional formulation containing prebiotic substances |
ATE357854T1 (de) | 2000-02-17 | 2007-04-15 | Wyeth Corp | Prebiotische substanzen enthaltende ernährungszusammensetzungen |
FI110668B (fi) | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
US7090862B2 (en) | 2001-03-30 | 2006-08-15 | Abbott Laboratories | Method of improving the antioxidant status of an infant |
AU2002320251A1 (en) | 2001-07-05 | 2003-01-21 | Vital Basics, Inc. | Compositions for improving mental performance |
DE10147100A1 (de) | 2001-09-25 | 2003-04-17 | Numico Res B V | Antiinfektive Kohlenhydrate |
US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
DE10204000A1 (de) | 2002-02-01 | 2003-08-14 | Nutricia Nv | Sialysierte Kohlenhydrate |
US7101565B2 (en) | 2002-02-05 | 2006-09-05 | Corpak Medsystems, Inc. | Probiotic/prebiotic composition and delivery method |
AR039170A1 (es) | 2002-03-28 | 2005-02-09 | Bio Dar Ltd | Co-granulos de dha y romero y metodos de uso |
US20040001817A1 (en) | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
OA13142A (en) | 2002-10-11 | 2006-12-13 | Wyeth Corp | Nutritional formulations containing synbiotic substances. |
FI20021989A0 (fi) | 2002-11-06 | 2002-11-06 | Halina Miller-Podraza | Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö |
KR101087412B1 (ko) | 2002-11-26 | 2011-11-25 | 유시카고 아르곤, 엘엘씨 | 미생물-매개 상피 장애를 예방 및 치료하기 위한 물질 및방법 |
GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
US7867541B2 (en) | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
US7951410B2 (en) | 2003-04-14 | 2011-05-31 | Mead Johnson Nutrition Company | Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid |
PT1638416E (pt) | 2003-06-23 | 2013-07-08 | Nestec Sa | Utilização de uma fórmula nutricional para função de barreira intestinal óptima |
WO2005000040A1 (en) | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
JP5236189B2 (ja) | 2003-12-05 | 2013-07-17 | チルドレンズ ホスピタル メディカル センター | オリゴ糖組成物および感染症の治療における該組成物の使用 |
US20060039954A1 (en) | 2003-12-23 | 2006-02-23 | Gierhart Dennis L | Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages |
US7416752B2 (en) | 2004-01-06 | 2008-08-26 | Sharp Ingrained Functional Foods, Inc. | Method of fortifying seeds with an essential fatty acid, fortified seed and food product |
ES1056525Y (es) | 2004-01-13 | 2004-07-16 | Perez Alfredo Pineiro | Halador de tres rodillos para redes y aparejos de pesca. |
US7851451B2 (en) | 2004-03-12 | 2010-12-14 | Mti Meta Tech Inc. | Formulations for mediating inflammatory bowel disorders |
US7090879B2 (en) | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
CN1972604B (zh) | 2004-06-22 | 2010-06-02 | 努特里希亚公司 | Hiv患者中屏障完整性的提高 |
EP1721611A1 (en) | 2005-04-21 | 2006-11-15 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
FR2872047B1 (fr) | 2004-06-23 | 2007-06-15 | Oreal | Composition pour peaux sensibles associant cation mineral et probiotique(s) |
EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
CN101155616A (zh) | 2005-04-08 | 2008-04-02 | 宝洁公司 | 用于人类美容有益效果的口服益生菌双歧杆菌的使用方法 |
US20060270739A1 (en) | 2005-04-28 | 2006-11-30 | Trustees Of Tufts College | Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation |
US20060247153A1 (en) | 2005-04-29 | 2006-11-02 | Mcmahon Robert J | Method of improving learning and memory in mammals |
US20060246146A1 (en) | 2005-04-29 | 2006-11-02 | Mcmahon Robert J | Method of increasing the salivary sialic acid content in a mammal |
US9179702B2 (en) | 2005-07-13 | 2015-11-10 | Abbott Laboratories | Liquid nutritional compositions containing unsaturated fatty acids |
US7664087B2 (en) | 2005-09-15 | 2010-02-16 | Samsung Electronics Co., Ltd | Method for generating a frame in an orthogonal frequency division multiple access communication system |
EP1776877A1 (en) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
EP1951060B1 (en) | 2005-11-04 | 2017-11-01 | Arla Foods Amba | A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof |
WO2007058523A1 (en) | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
CA2636724A1 (en) | 2006-01-09 | 2007-08-02 | Children's Hospital Medical Center | Adiponectin for treatment of various disorders |
US20070173438A1 (en) | 2006-01-13 | 2007-07-26 | The Scripps Research Institute | [PSI[CH2NH]PG4] glycopeptide antibiotic analogs |
EP1986665B1 (en) | 2006-01-19 | 2018-05-02 | TerraVia Holdings, Inc. | Microalgae-derived compositions for improving the health and appearance of skin |
MY149913A (en) | 2006-03-07 | 2013-10-31 | Nestec Sa | Synbiotic mixture |
BRPI0708701A2 (pt) | 2006-03-10 | 2011-06-07 | Nutricia Nv | uso de um sacarìdeo não digerìvel solúvel em água |
US20090143301A1 (en) | 2006-03-23 | 2009-06-04 | Nestec S.A. | High calorie nutritional supplement |
MY148280A (en) | 2006-03-23 | 2013-03-29 | Nutricia Nv | Preterm formula |
US20070255598A1 (en) | 2006-03-29 | 2007-11-01 | Mccarthy Nancy J | Compliance aid, kits comprising the compliance aid, and methods of use |
WO2007114683A1 (en) | 2006-03-30 | 2007-10-11 | N.V. Nutricia | Milk oligosaccharides for stimulating the immune system |
CA2655665A1 (en) | 2006-05-26 | 2007-12-06 | Nestec S.A. | Methods of use and nutritional compositions of touchi extract |
US20080003330A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
US20080003329A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
EP2164349B1 (en) | 2006-08-04 | 2014-09-10 | SHS International Ltd. | Protein free formula |
EP1887017A1 (en) | 2006-08-09 | 2008-02-13 | Friesland Brands B.V. | Prebiotic carbohydrate |
US8361756B2 (en) | 2006-09-15 | 2013-01-29 | The Regents Of The University Of California | Bifidobacterial gene sequences and their use |
US20080089981A1 (en) | 2006-10-17 | 2008-04-17 | N.V. Nutricia | Ketogenic diet |
NL1032840C2 (nl) | 2006-11-09 | 2008-05-13 | Friesland Brands Bv | Probiotische hydrolysaatvoeding voor kinderen. |
NL1033521C2 (nl) | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Kindervoedingen met geoptimaliseerde aminozuursamenstelling. |
US20100063002A1 (en) | 2007-03-13 | 2010-03-11 | Bernd Stahl | Method of improving skills with a composition comprising non-digestible saccharide |
NL1033698C2 (nl) | 2007-04-16 | 2008-10-20 | Friesland Brands Bv | Functioneel serumeiwitproduct voor toepassing in kindervoeding en therapeutische samenstellingen, en werkwijzen ter bereiding daarvan. |
WO2008139984A1 (en) | 2007-04-26 | 2008-11-20 | Eisai R & D Management Co., Ltd. | Cinnamide compounds for dementia |
US8197872B2 (en) | 2007-05-17 | 2012-06-12 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
JP5766947B2 (ja) | 2007-09-07 | 2015-08-19 | チルドレンズ ホスピタル メディカル センター | 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用 |
JP2009075285A (ja) | 2007-09-20 | 2009-04-09 | Fujifilm Corp | 半導体デバイスの剥離液、及び、剥離方法 |
US10251899B2 (en) | 2007-10-08 | 2019-04-09 | Mead Johnson Nutrition Company | Method for improving stool characteristics in infants |
US20090118229A1 (en) | 2007-11-07 | 2009-05-07 | Bristol-Myers Squibb Company | Carotenoid-containing compositions and methods |
EP2060257A1 (en) * | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
EP2217246B1 (en) | 2007-11-08 | 2014-12-17 | Nestec S.A. | Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
WO2009067000A1 (en) | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
WO2009079353A1 (en) | 2007-12-14 | 2009-06-25 | Enanta Pharmaceuticals, Inc. | Triazole-containing macrocyclic hcv serine protease inhibitors |
EP2072052A1 (en) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
WO2009102193A1 (en) | 2008-02-12 | 2009-08-20 | N.V. Nutricia | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
NL2001377C2 (nl) | 2008-03-14 | 2009-09-15 | Friesland Brands Bv | Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen. |
CN101998859B (zh) | 2008-03-18 | 2014-03-05 | 亚历山大·弗拉基米罗维奇·季科夫斯基 | 用于预防与抗生素肠道给药相关的生态失调的药物组合物 |
EP2127661A1 (en) | 2008-05-27 | 2009-12-02 | Nestec S.A. | Probiotics to improve gut microbiotica |
EP2143341A1 (en) | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
GB0809921D0 (en) | 2008-05-30 | 2008-07-09 | Clasado Inc | Product and process therefor |
WO2010023178A1 (en) | 2008-08-28 | 2010-03-04 | Chr. Hansen A/S | Pharmaceuticals comprising a bacterial polysaccharide |
WO2010065652A1 (en) | 2008-12-02 | 2010-06-10 | Prolacta Bioscience, Inc. | Human milk permeate compositions and methods of making and using same |
CN102257128A (zh) | 2008-12-19 | 2011-11-23 | 詹内怀恩生物技术股份有限公司 | 岩藻糖化化合物的合成 |
US8425955B2 (en) | 2009-02-12 | 2013-04-23 | Mead Johnson Nutrition Company | Nutritional composition with prebiotic component |
JP2012520325A (ja) | 2009-03-13 | 2012-09-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | プレバイオティックオリゴ糖 |
CN102459294A (zh) | 2009-04-07 | 2012-05-16 | 格礼卡姆股份公司 | 2’-o-岩藻糖基乳糖的合成 |
US10576110B2 (en) | 2009-05-11 | 2020-03-03 | Societe Des Produits Nestle S.A. | Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders |
TWI381845B (zh) | 2009-05-21 | 2013-01-11 | Univ Nat Taiwan | 預防和治療幽門螺旋桿菌感染的組成物 |
ES2651067T3 (es) | 2009-07-06 | 2018-01-24 | Children's Hospital Medical Center | Inhibición de la inflamación con oligosacáridos de la leche |
ES2525565T3 (es) | 2009-07-15 | 2014-12-26 | N.V. Nutricia | Fucosilactosa como oligasacárido no digerible idéntico a la leche humana para tratar y/o prevenir infecciones víricas |
DK2459203T3 (en) | 2009-07-30 | 2019-02-18 | Dupont Nutrition Biosci Aps | Lactic Acid Bacteria and Bifidobacteria for the Treatment of Endotoxemia |
EP2459202A1 (en) | 2009-07-31 | 2012-06-06 | Nestec S.A. | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
US20110027412A1 (en) | 2009-07-31 | 2011-02-03 | Kris Eugene Spence | Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health |
JPWO2011024468A1 (ja) | 2009-08-27 | 2013-01-24 | 興和株式会社 | 新規なスルホンアミド誘導体及びこれを含有する医薬 |
EP2525811B2 (en) | 2010-01-19 | 2019-02-27 | Abbott Laboratories | A composition comprising lactobacillus rhamnosus hn001 and prebiotics for use in the treatment of allergic lung disease |
NL2004201C2 (en) | 2010-02-05 | 2011-08-08 | Friesland Brands Bv | Use of sialyl oligosaccharides to modulate the immune system. |
WO2011136636A1 (en) | 2010-04-27 | 2011-11-03 | N.V. Nutricia | Use of 6'-sialyl lactose in infant nutrition |
EP2563165A1 (en) | 2010-04-27 | 2013-03-06 | N.V. Nutricia | Use of 6'-sialyl lactose in infant and toddler nutrition |
EP3369739A1 (en) | 2010-07-12 | 2018-09-05 | The Regents of The University of California | Bovine milk oligosaccharides |
EP2465509A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating acute respiratory tract infections |
EP2465507A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
EP2455387A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2465508A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
DK2658549T3 (da) | 2010-12-31 | 2020-06-29 | Abbott Lab | Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler |
NZ611807A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
EP2658401A2 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Human milk oligosaccharides to promote growth of beneficial bacteria |
ES2719404T3 (es) | 2010-12-31 | 2019-07-10 | Abbott Lab | Composiciones nutricionales que comprenden oligosacáridos de leche humana para el uso en el tratamiento y/o prevención de la infección por rotavirus entérico |
MY166945A (en) | 2010-12-31 | 2018-07-25 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
NZ612105A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Human milk oligosaccharides for modulating inflammation |
MX354524B (es) | 2010-12-31 | 2018-03-08 | Abbott Lab | Métodos para usar los oligosacáridos de leche humana para mejorar la salud respiratoria de las vías aéreas. |
BR112013016914A2 (pt) | 2010-12-31 | 2019-09-24 | Abbott Lab | combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica |
US9567361B2 (en) | 2011-05-13 | 2017-02-14 | Glycosyn LLC | Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics |
US20130012472A1 (en) | 2011-07-05 | 2013-01-10 | Boston College | Composition and methods of inhibiting gastrointestinal pathogen infection |
WO2013016111A1 (en) | 2011-07-22 | 2013-01-31 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
WO2013057062A1 (en) | 2011-10-18 | 2013-04-25 | Nestec S.A. | Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery |
GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
US9896470B2 (en) | 2012-06-14 | 2018-02-20 | Glycom A/S | Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof |
AU2016233529B2 (en) | 2015-03-13 | 2022-03-10 | Evolve Biosystems, Inc. | Compositions that metabolize or sequester free sugar monomers and uses thereof |
RU2725883C2 (ru) | 2015-04-23 | 2020-07-07 | Компани Жервэ Данон | Композиция для сокращения выработки кишечного газа |
AU2016303003A1 (en) | 2015-08-04 | 2017-12-07 | Société des Produits Nestlé S.A. | Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants |
CN108289919A (zh) | 2015-10-19 | 2018-07-17 | 株式会社明治 | 面向婴儿的抗过敏剂 |
EP3366299A4 (en) | 2015-10-19 | 2019-04-17 | Meiji Co., Ltd | MEANS OF PREVENTING INFECTIONS FOR SMALL CHILDREN |
CN109069549A (zh) | 2016-03-11 | 2018-12-21 | 进化生物系统股份有限公司 | 用于断奶的食物组合物 |
SG11201807809XA (en) | 2016-03-11 | 2018-10-30 | Evolve Biosystems Inc | A transient commensal microorganism for improving gut health |
EP3443969B1 (en) | 2016-04-13 | 2021-12-22 | Meiji Co., Ltd. | Use of bifidobacteria for improving developmental quotient in neonates |
GB201611486D0 (en) | 2016-06-30 | 2016-08-17 | Promovita Ingredients Ltd | Composition for treatment and/or nutrition of poultry |
EP3478093A4 (en) | 2016-07-01 | 2020-03-04 | Evolve Biosystems, Inc. | METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM |
US20200315235A1 (en) | 2016-10-05 | 2020-10-08 | N. V. Nutricia | Normalization of the Intestinal Microbiota Composition in Infants or Toddlers Fed with an Amino Acid-Based Nutritional Composition |
EP3551201A4 (en) | 2016-12-06 | 2020-06-24 | Pendulum Therapeutics, Inc. | METHOD AND COMPOSITIONS RELATING TO INSULATED AND CLEANED MICROBES |
WO2018112366A1 (en) | 2016-12-15 | 2018-06-21 | The Regents Of The University Of California | Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto |
US20180200312A1 (en) | 2017-01-17 | 2018-07-19 | The Regents Of The University Of California | Methods and Compositions for Enhancing Memory and/or Reducing Fear and/or Pain of a Host by Administering a Probiotic |
KR102089836B1 (ko) | 2017-03-15 | 2020-03-16 | (주)바이오일레븐 | 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법 |
JP2018177703A (ja) | 2017-04-14 | 2018-11-15 | 株式会社明治 | Toll様受容体2活性化用組成物 |
WO2019000098A1 (en) | 2017-06-30 | 2019-01-03 | Wilfrid Laurier University | THERMOSIPHON FILLED WITH LIQUID TO A FORCED CIRCULATION PHASE |
SG11202002325VA (en) | 2017-09-13 | 2020-04-29 | Evolve Biosystems Inc | Metabolomic revision of mammalian infants |
-
2011
- 2011-12-22 NZ NZ611807A patent/NZ611807A/en not_active IP Right Cessation
- 2011-12-22 CA CA2822219A patent/CA2822219C/en active Active
- 2011-12-22 MX MX2013007692A patent/MX2013007692A/es active IP Right Grant
- 2011-12-22 US US13/334,933 patent/US9539269B2/en active Active
- 2011-12-22 WO PCT/US2011/067018 patent/WO2012092156A1/en active Application Filing
- 2011-12-22 MY MYPI2017000647A patent/MY197622A/en unknown
- 2011-12-22 BR BR112013016905A patent/BR112013016905A2/pt not_active IP Right Cessation
- 2011-12-22 CN CN201610935257.5A patent/CN107019701B/zh active Active
- 2011-12-22 SG SG2013050067A patent/SG191392A1/en unknown
- 2011-12-22 EP EP11811266.3A patent/EP2658547A1/en not_active Withdrawn
- 2011-12-22 SG SG10201603856PA patent/SG10201603856PA/en unknown
- 2011-12-22 MY MYPI2013002514A patent/MY171620A/en unknown
- 2011-12-22 SG SG10202110501RA patent/SG10202110501RA/en unknown
-
2013
- 2013-06-28 MX MX2020010780A patent/MX2020010780A/es unknown
- 2013-06-28 MX MX2022011064A patent/MX2022011064A/es unknown
-
2017
- 2017-01-09 US US15/401,488 patent/US10471081B2/en active Active
-
2019
- 2019-11-11 US US16/680,054 patent/US11179406B2/en active Active
- 2019-11-27 US US16/698,422 patent/US11690859B2/en active Active
-
2023
- 2023-06-30 US US18/345,357 patent/US20230338404A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MY197622A (en) | 2023-06-28 |
SG191392A1 (en) | 2013-08-30 |
WO2012092156A1 (en) | 2012-07-05 |
MX2013007692A (es) | 2013-08-15 |
MX2020010780A (es) | 2020-10-28 |
US20120172319A1 (en) | 2012-07-05 |
CA2822219C (en) | 2020-12-29 |
SG10202110501RA (en) | 2021-11-29 |
US20230338404A1 (en) | 2023-10-26 |
NZ611807A (en) | 2015-02-27 |
CN103338775A (zh) | 2013-10-02 |
US20200078385A1 (en) | 2020-03-12 |
US20170224714A1 (en) | 2017-08-10 |
US11690859B2 (en) | 2023-07-04 |
US9539269B2 (en) | 2017-01-10 |
US20200093846A1 (en) | 2020-03-26 |
CA2822219A1 (en) | 2012-07-05 |
EP2658547A1 (en) | 2013-11-06 |
SG10201603856PA (en) | 2016-07-28 |
MY171620A (en) | 2019-10-21 |
MX2022011064A (es) | 2022-10-07 |
US10471081B2 (en) | 2019-11-12 |
CN107019701A (zh) | 2017-08-08 |
CN107019701B (zh) | 2020-07-28 |
US11179406B2 (en) | 2021-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013016905A2 (pt) | métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano | |
PH12017500874A1 (en) | Human milk oligosaccharides for modulating inflammation | |
BR112013016606A2 (pt) | processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios | |
MY174541A (en) | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection | |
PH12016500773A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section | |
MY169326A (en) | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract | |
MX352040B (es) | Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. | |
EA201790109A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
BR112013016929A2 (pt) | oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas | |
MY196432A (en) | Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health | |
IN2015DN03862A (pt) | ||
DK2498628T3 (da) | Produkter til at formindske forekomsten af nekrotiserende enterocolitis, kolik og korttarmsyndrom hos et spædbarn, en tumling eller et barn | |
TR201904719T4 (tr) | Diyet proteinlerine karşı toleransın oral indüksiyonu için sindirilemeyen oligosakkaridler. | |
WO2012129341A3 (en) | Disease detection in plants | |
BR112014001472A2 (pt) | galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal | |
BR112013011088A2 (pt) | composições de cereal em pó compreendendo microorganismos probióticos não replicantes | |
MY175195A (en) | Nutritional compositions | |
WO2014179771A8 (en) | Dosing combinations for reducing undesired humoral immune responses | |
WO2013033092A3 (en) | Streptococcus suis pilus antigens | |
NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
BR112014019486A8 (pt) | Uso de um oligossacarídeo não digerível como um suplemento materno | |
PH12017500873A1 (en) | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides | |
IN2015KN00091A (pt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |